Pulmonary Embolism (PE) - Risk Factors, Symptoms, Diagnosis and Treatment

Pulmonary embolism (PE) is a severe cardiovascular disorder marked by the obstruction of the pulmonary arteries by blood clots, frequently developed after deep vein thrombosis (DVT). Affecting over 900,000 individuals per year in the United States, pulmonary embolism ranks as the third most common cause of cardiovascular mortality worldwide. Potential risk factors include extended periods of immobility, surgical procedures, specific medical disorders, such as cancer, and the utilization of contraception or hormone medication. Manifestations such as abrupt dyspnea, angina, and vertigo require urgent medical intervention. The diagnosis of pulmonary embolism includes imaging studies, such as CT pulmonary angiography (CTPA) and bloodwork. The usual treatment protocol involves using anticoagulants, thrombolytics, and occasionally surgical procedures, such as catheter-assisted thrombus removal or inferior vena cava filters. Preventive measures predominantly target the reduction of blood clot risk by using anticoagulants, prompt postoperative mobility, and elevation of the legs. Considering its seriousness, timely identification and therapy significantly decrease mortality associated with pulmonary embolism.

Authors

Institutions

Publication Details

Journal
˜The œAmerican journal of patient health info.
Published
2025-02-12
DOI
https://doi.org/10.69512/ajphi.v2i1.70
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulmonary Embolism (PE) - Risk Factors, Symptoms, Diagnosis and Treatment

Apurwa Karki, L. Manandhar, Sahira Shrestha
˜The œAmerican journal of patient health info.
Venous Thromboembolism Diagnosis and Management
article

Pulmonary Embolism (PE) - Risk Factors, Symptoms, Diagnosis and Treatment

Apurwa Karki, L. Manandhar, Sahira Shrestha
article en

Abstract

Pulmonary embolism (PE) is a severe cardiovascular disorder marked by the obstruction of the pulmonary arteries by blood clots, frequently developed after deep vein thrombosis (DVT). Affecting over 900,000 individuals per year in the United States, pulmonary embolism ranks as the third most common cause of cardiovascular mortality worldwide. Potential risk factors include extended periods of immobility, surgical procedures, specific medical disorders, such as cancer, and the utilization of contraception or hormone medication. Manifestations such as abrupt dyspnea, angina, and vertigo require urgent medical intervention. The diagnosis of pulmonary embolism includes imaging studies, such as CT pulmonary angiography (CTPA) and bloodwork. The usual treatment protocol involves using anticoagulants, thrombolytics, and occasionally surgical procedures, such as catheter-assisted thrombus removal or inferior vena cava filters. Preventive measures predominantly target the reduction of blood clot risk by using anticoagulants, prompt postoperative mobility, and elevation of the legs. Considering its seriousness, timely identification and therapy significantly decrease mortality associated with pulmonary embolism.

˜The œAmerican journal of patient health info.Vol. 2(1)
Nepal Medical College Teaching Hospital (NP), Rajiv Gandhi University of Health Sciences (IN)
Openalex Percentile: Top 94%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pulmonary Embolism (PE) - Risk Factors, Symptoms, Diagnosis and Treatment — Apurwa Karki, L. Manandhar, et al. · ˜The œAmerican journal of patient health info. (2025) | TGRS Research Map | TGRS